Screening service for neuroactive drugs with primary neuronal cell cultures

NeuroProof technology provides our customers with important information during the pre-clinical drug development. Thereby they save time and costs and are decreasing the attrition rate. Our screening services are organized according to established experimental protocols. Thus we assure a high accuracy in the reproducibility of our results and offer attractive conditions. In addition to the dose-response curves, our customers obtain useful indication of the compounds mode of action, about neurotoxicity and efficiency of compound compared to similar substances as well as the effects of compound combinations.